Maria Munoz

Abstract In EMBER-3 (NCT04975308), among patients with ER + , HER2- advanced breast cancer (ABC) with recurrence/progression on/after endocrine therapy (ET), imlunestrant significantly prolonged PFS versus standard ET in patients with ESR1 mutations, and imlunestrant + abemaciclib prolonged PFS versus imlunestrant in the overall population. We report the incidence, severity, timing, and management of common treatment-emergent adverse events (TEAEs), including safety profiles of select subgroups.

1 Introduction Health professions prioritise balanced care and clinical competencies, essential for professional–patient communication [1]. Research on learning styles (LS) emerged to understand individual learning differences beyond intelligence alone [2]. Studies on students' preferred LS help explain these differences [3]. LS research fits within the study of individual differences and includes stylistic preferences in how people organise stimuli and construct meaning [4].